Engineers Gate Manager LP

Position in RGNX — REGENXBIO Inc.

CIK 1620220 NEW YORK, NY

Position in RGNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$533,806

+$246,912 QoQ

Shares Held

63,700

+114.3% QoQ

Ownership

0.123%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Engineers Gate Manager LP holds $239,656,317 across 145 Biotechnology names. RGNX ranks #68 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	158,792	$25,965,667
2	BMRN	Biomarin Pharmaceutical Inc	436,860	$24,678,221
3	BBIO	BridgeBio Pharma, Inc.	243,729	$18,099,315
4	JAZZ	Jazz Pharmaceuticals plc	92,990	$17,579,759
5	ALNY	Alnylam Pharmaceuticals, Inc.	32,502	$10,753,936
6	IONS	Ionis Pharmaceuticals Inc	133,827	$10,049,069
7	TVTX	Travere Therapeutics, Inc.	254,401	$7,558,253
8	ROIV	Roivant Sciences Ltd.	256,447	$7,103,581

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$533,806	63,700	+114.3%	Shares	Sole	2026-05-15
2025-09-30	$286,894	29,730	-42.6%	Shares	Sole	2025-11-14
2025-06-30	$425,384	51,813	+2.1%	Shares	Sole	2025-08-14
2025-03-31	$362,812	50,743	+11.1%	Shares	Sole	2025-05-15
2024-12-31	$353,175	45,689	+128.8%	Shares	Sole	2025-02-14
2024-06-30	$233,613	19,967	-21.7%	Shares	Sole	2024-08-14
2023-12-31	$457,850	25,507	+28.8%	Shares	Sole	2024-02-14
2021-12-31	$647,361	19,797	+1.6%	Shares	Sole	2022-02-14
2021-03-31	$664,326	19,476	+209.6%	Shares	Sole	2021-05-17
2020-12-31	$285,314	6,290	-49.4%	Shares	Sole	2021-02-16
2020-09-30	$341,963	12,426	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.